Azelis Group NV Stocks

8.94Last Updated 02.04.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

€ 2.51B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
8.94
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients in Belgium and internationally. It serves various segments in life sciences, including personal care, pharma, food and health, specialty agri/horti, and homecare and industrial chemicals; and industrial chemicals industry, such as CASE, rubber and plastic additives, lubricants and metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper applications. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium. Azelis Group NV operates as a subsidiary of Akita I S.À R.L.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, underpriced

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of AZE.BR is 12 and suggests 35% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks